Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 225,173 |
|
|||||
| News | - | ||||||
| Day High | 0.2597 | Low High |
|||||
| Day Low | 0.2422 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Theriva Biologics Inc | TOVX | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0063 | 2.61% | 0.2473 | 19:59:21 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.246 | 0.2422 | 0.2597 | 0.257 | 0.241 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 494 | 225,173 | $ 0.2531651 | $ 57,006 | - | 0.1972 - 1.20 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 20:00:00 | 153 | $ 0.257 | USD |
Theriva Biologics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.26M | 17.04M | - | 0 | -18.35M | -1.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Theriva Biologics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TOVX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.266 | 0.269 | 0.23 | 0.2506602 | 273,449 | -0.0187 | -7.03% |
| 1 Month | 0.3615 | 0.43 | 0.23 | 0.3167088 | 1,548,746 | -0.1142 | -31.59% |
| 3 Months | 0.4801 | 0.5446 | 0.23 | 0.3325295 | 614,711 | -0.2328 | -48.49% |
| 6 Months | 0.60 | 0.6845 | 0.23 | 0.3628618 | 339,616 | -0.3527 | -58.78% |
| 1 Year | 0.70 | 1.20 | 0.1972 | 0.6403203 | 365,007 | -0.4527 | -64.67% |
| 3 Years | 0.80 | 1.26 | 0.1972 | 0.6512729 | 242,519 | -0.5527 | -69.09% |
| 5 Years | 0.80 | 1.26 | 0.1972 | 0.6512729 | 242,519 | -0.5527 | -69.09% |
Theriva Biologics Description
| Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11, leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. |
